Table 2 Prevalences of morbidities due to neonatal hypoglycaemia
From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia
| Single health-state outcomes: | Number of prevalence reportsa | Sum of cases | Sum of study populations | Weighted mean prevalence | Minimum prevalence | Maximum prevalence |
|---|---|---|---|---|---|---|
| Cerebral palsy | 4 [1, 23, 24] | 53 | 1020 | 5.20% | 0.38% | 14.89% |
| Childhood epilepsies and convulsions | 3 [23, 29] | 7604 | 1,421,813 | 0.53% | 0.52% | 4.58% |
| Learning disabilities | 7 [1, 23,24,25,26,27,28] | 205 | 1314 | 15.60% | 2.38% | 54.00% |
| Severe learning disabilities | 1 [23] | 9 | 278 | 3.24% | 3.24% | 3.24% |
| Vision disorders/blindness | 1 [23] | 2 | 270 | 0.74% | 0.74% | 0.74% |